Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06488742

The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis

Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in the Treatment of Patients With Mild Atopic Dermatitis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Nexgen Dermatologics, Inc. · Industry
Sex
All
Age
12 Years – 75 Years
Healthy volunteers
Accepted

Summary

Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceutical to help this population

Detailed description

There are many treatment options available for atopic dermatitis yet many patients still suffer from the underlying symptomatology. It is important to explore other treatment alternatives to help this population.

Conditions

Interventions

TypeNameDescription
OTHER3% kanuka oilTo assess the efficacy in patients with mild atopic dermatitis, 3% kanuka oil will be applied twice a day for 28 days. 3% kanuka oil is a naturally occurring extract from the kanuka tree and is considered an over-the-counter agent.

Timeline

Start date
2023-11-01
Primary completion
2024-12-10
Completion
2025-03-20
First posted
2024-07-05
Last updated
2024-07-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06488742. Inclusion in this directory is not an endorsement.